"Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases".

@article{Seckl2010HyperglycosylatedHI,
  title={"Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases".},
  author={Michael J. Seckl and Philip Savage and Barry William Hancock and Ross Stuart Berkowitz and Donald Peter Goldstein and John R. Lurain and Julian C. Schink and Faye Maria Cagayan and François R Golfier and Hextan Y. S. Ngan and Norio Wake and Ray Osborne and Shigeru Sasaki and Rafael Cort{\'e}s Charry and L. C. Wong and Paradan K Sekharan and M A S Djamhoer and Leon M Massuger and Paulo Belfort and Seung Jo Kim and Chan Lee and Sang Geun Jung},
  journal={Gynecologic oncology},
  year={2010},
  volume={117 3},
  pages={505-6; author reply 506-7}
}
We read with interest the paper of LA Cole and CY Muller (ref. Gynecol. Oncol. 2010 Jan, 116(1): 3–9, epub. 2009 Oct 12) on the use of hCG-H in the management of quiescent and chemorefractory gestational trophoblastic disease (GTD). The primary author is a very well respected clinical chemist who has contributed much to the field of hCG and its role in… CONTINUE READING